NuCana to Participate in Three Upcoming Investor Conferences

On September 1, 2021 NuCana plc (NASDAQ: NCNA) reported that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will participate in three upcoming virtual investor conferences (Press release, Nucana BioPharmaceuticals, SEP 1, 2021, View Source [SID1234587108]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: Citi’s 16th Annual BioPharma Virtual Conference
Dates: September 8-10, 2021

Event: H.C. Wainwright 23rd Annual Global Investment Conference
Dates: September 13-15, 2021

Event: Oppenheimer’s Virtual Fall Healthcare Life Sciences & MedTech Summit
Presentation Date: Wednesday, September 22, 2021
Presentation Time: 9:05 AM ET

A pre-recorded webcast of the presentation at the H.C. Wainwright 23rd Annual Global Investment Conference will be made available on the Company’s website starting on Monday, September 13, 2021, at 7:00 AM ET. The presentation at the Oppenheimer Virtual Fall Healthcare Life Sciences & MedTech Summit will be webcast live. Both presentations will be available for replay under "Events & Presentations" in the Investors section of the Company’s website at www.nucana.com.